Image 1 caroussel

eJGSO 2020 - Scientific Program


Scientific program


Tuesday 24th November
10:00-10:10 Opening ceremony
10:10-12:00 In vivo single cell & Imaging
All day Poster sessions by Axis


Wednesday 25th November
10:00-11:30 Séminaire de l'axe 4 "médecines alternatives, parallèles, complémentaires"
11:30-12:30 Cancer: old and new risk factors
12:30-12:40 ePoster Awards ceremony
All day Poster sessions by Axis


Thursday 26th November
10:00-12:00 Inflammation & Cancer
All day Poster sessions by Axis


Friday 27th November
10:00-12:00 RNA & Cancer
12:00-12:15 Closing ceremony




Tuesday 24th November

10:00 - 10:10 : Opening ceremony

Muriel MATHONNET, Scientific director of Cancéropôle Grand Sud-Ouest


10:10 - 12:00 : Plenary session

  • In vivo single cell & Imaging
    Chair: Julie PANNEQUIN
    • KEYNOTE SPEAKER: Jacco VAN RHEENEN, The Netherlands Cancer Institute, Amsterdam (The Netherlands) - Intravital microscopy revealed cancer stem cell plasticity to be important for metastasis
    • Data integration and single cell approaches to characterise the tumour micro-environment - Vera PANCALDI, Cancer Research Center of Toulouse
    • KEYNOTE SPEAKERAnne RIOS, The Princess Maxima Center, Utrecht (The Netherlands) - Single-cell 3D imaging technologies: uncovering biology cell by cell



Wednesday 25th November

10:00 - 11:30 : Session d'axe (en français)

  • Séminaire de l'axe 4: "médecines alternatives, parallèles, complémentaires" 
    Chair: Béatrice Jacques 
    • Nicolas Molinari, CHU Montpellier - Comment envisager un projet de recherche autour des "burn healer" ?
    • Nicolas Calcagni, Université de Bordeaux - Vers un nouveau gold standard de l'évaluation des médecines complémentaires et alternatives? Réflexions et illustrations sur les protocoles expérimentaux à cas uniques
    • Sébastien MAS, Epidaure, ICM - Le jeûne en oncologie : une médecine complémentaire pour le corps ou pour l'esprit ?
    • Pascal Ragouet, Centre Emile Durkheim - Comment faire du translationnel en étant dans la marge? Warburg au centre d'une patient narrative driven research.


11:30 - 12:00 : Plenary session

  • Cancer: old and new risk factors 
    Chair: Cyrille DELPIERRE 
    • KEYNOTE SPEAKER: Paolo VINEIS, Imperial College, London (England)



Thursday 26th November

10:00 - 12:00 : Plenary session

  • Inflammation & Cancer 
    Chair: Majid KHATIB 
    • KEYNOTE SPEAKER: Florian GRETEN, Institute for Tumor Biology and Experimental Therapy, Frankfurt (Germany) - Mechanisms driving cell plasticity in the colorectal tumor microenvironment
    • High endothelial venules (HEVs): specialized blood vessels mediating lymphocyte entry to lymph nodes and tumors’ - Jean-Philippe GIRARD, Institute of Pharmacoly and Structural Biology, Toulouse
    • A novel mechanism linking replication stress and inflammation in oncogene-induced senescence - Philippe PASERO, Institute of Human Genetics, Montpellier
    • KEYNOTE SPEAKERFatima MECHTA-GRIGORIOU, Curie Institute, Paris - Role of fibroblast heterogeneity in immunosuppression and resistance to immunotherapy



Friday 27th November

10:00 - 12:00 : Plenary session

  • RNA & Cancer 
    Chair: Stefania MILLEVOI 
    • KEYNOTE SPEAKER: Eleonora LEUCCI, Department of Oncology, KU Leuven (Belgium) - Long non-coding RNA SAMMSON and beyond: uncoupling cytosolic and mitochondrial-translation as an effective anti-melanoma strategy
    • Translational regulation in normal and cancer cells: insights from single molecule imaging - Edouard BERTRAND, Institute of Molecular Genetics of Montpellier
    • Translational control of DNA replication and repair in pancreatic cancer - Yvan MARTINEAU, Cancer Research Center of Toulouse
    • KEYNOTE SPEAKER: Stéphan VAGNER, Curie Institute, Paris - mRNA translation plasticity in persistent cancer cells